The Miller Firm is currently pursuing cases involving birth defects experienced following a mother’s ingestion of Zofran during her first trimester. Zofran is an anti-nausea drug that has been used to treat morning sickness in pregnant women. Various recent studies have linked Zofran to significant increased risk of birth defects including heart defects, cleft palate, and cleft lip. If you or a loved one has been affected by Zofran ingestion, please call us today for a free consultation 1-800-882-2525.
The use of the drug for the population of pregnant woman was not approved by the FDA. In fact, Zofran was listed as a Pregnancy Category B drug meaning that there was not sufficient safety information to indicate the drug for usage in pregnant woman. Nonetheless, the manufacturer, GlaxoSmithKline (GSK) marketed the drug “off-label” for use by pregnant women due to the significant revenue achieved from the many pregnant women experiencing nausea. This resulted in a June 2012 settlement with the Department of Justice for 3 Billion dollars over these illegal marketing practices.
Various studies have linked a significant increase in the risk of birth defects following a mother’s ingestion of Zofran. A 2013 study found that the risk of heart defects such as Atrial Septal Defect, Ventricular Septal Defect, and Heart Murmur were twice as likely to occur with a mother ingesting Zofran in her first trimester. Further, a study in 2012 found that children were twice as likely to have disorders such as cleft palate and cleft lip. If you’d like more information about the litigation please follow our blog to stay updated with scientific and litigation updates.
CALL US NOW
Contact us at 1-800-882-2525 or email us at [email protected] for a free consultation. Our lawyers have the ability to represent clients across the country against the manufacturers of Zofran and would pursue your case as an individual lawsuit if it meets our qualifying criteria.